✦ LIBER ✦

Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

✍ Scribed by Steven B. Deitelzweig; Jay Lin; Charles Kreilick; Mohamed Hussein; David Battleman

Book ID: 107648681
Publisher: Springer Healthcare Communications
Year: 2010
Tongue: English
Weight: 315 KB
Volume: 27
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-010-0056-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical predictors of prophylaxis use p

Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER)

✍ N. KUCHER; D. SPIRK; C. KALKA; L. MAZZOLAI; D. NOBEL; M. BANYAI; B. FRAUCHIGER; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Therapy of venous thromboembolism in pat

Therapy of venous thromboembolism in patients with brain metastases

✍ David Schiff; Lisa M. Deangelis 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Practical problems and resource implicat

Practical problems and resource implications with the use of warfarin for venous thromboembolism in patients with cancer

✍ P. G. Morris; C. Davenport; D. O’Dwyer; C. O’Callaghan; O. S. Breathnach; L. Gro 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

Incidence rates, clinical profile, and o

Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study

✍ Frederick A. Spencer; Cathy Emery; Samuel W. Joffe; Luigi Pacifico; Darleen Less 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 262 KB

Prophylactic recombinant erythropoietin

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis

✍ Elias J. Anaissie; Elizabeth A. Coleman; Julia A. Goodwin; Robert L. Kennedy; Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective st

Clinical outcome of patients with venous

Clinical outcome of patients with venous thromboembolism and recent major bleeding: findings from a prospective registry (RIETE)

✍ J. A. NIETO; A. D. DE TUESTA; P. J. MARCHENA; G. TIBERIO; J. A. TODOLI; A. L. SA 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB